1 三村治 : 甲状腺眼症. 日本眼科学会雑誌 2009 ; 113 : 1015-1030.
2 Bartalena L, et al : Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 2008 ; 18 : 333-346.
3 長内一ら : 甲状腺眼症患者242例における臨床的血液学的検討. あたらしい眼科 1998 ; 15 : 1043-1047.
4 Kuriyan AE, et al : The eye and thyroid disease. Curr Opin Ophthalmol 2008 ; 19 : 499-506.
5 Orgiazzi J : Pathogenesis. In : Wiersinga WM, et al, editors. Graves' Orbitopathy : A multidisciplinary approach. 1st edition. Basel : Karger ; 2007. p.41-56.
6 Hoffman ON : Myopathies affecting the extraocular muscles. In : Miller NR, et al, editors. Walsh and Hoyt's Clinical Neuro-ophthalmology. 6th edition. Philadelphia : Lippincott Williams & Wilkins ; 2005. p.1085-1131.
7 Prummel MF, et al : Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Arch Intern Med 1990 ; 150 : 1098-1101.
8 中山智彦ら : 今日の日本人の眼球突出度について. 臨床眼科 1992 ; 46 : 1031-1035.
9 三村治ら : 甲状腺眼症. 神経内科 2009 ; 70 : 29-35.
11 Lane CM, et al : Management of very severe Graves' orbitopathy (Dysthyroid optic neuropathy). In : Wiersinga WM, et al, editors. Graves' Orbitopathy : A multidisciplinary approach. 1st edition. Basel : Karger ; 2007. p.153-159.
14 Tanda ML, et al : Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyroidism seen at a single center. J Clin Endocrinol Metab 2013 ; 98 : 1443-1449.
15 Perros P, et al : Natural history of thyroid associated opthalmopathy. Clin Endocrinol 1995 ; 42 : 45-50.
17 Cawood TJ, et al : Smoking and thyroid-associated ophthalmopathy : a novel explanation of the biological link. J Clin Endocrinol Metab 2007 ; 92 : 59-64.
18 高木峰夫ら : 甲状腺眼症治療のEBM. あたらしい眼科 2006 ; 23 : 735-742.
19 Bartalena L, et al : Efficacy and safety of three different cumulative doses of intravenous methyl prednisolone for moderate to severe and active Graves' orbitopathy. J Clin Endocrinol Metab 2012 ; 97 : 4454-4463.
21 Ohtsuka K, et al : Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves' ophthalmopathy. Jpn J Ophthalmol 2002 ; 46 : 563-567.
22 木村亜紀子 : 甲状腺眼症と眼瞼. 神経眼科 2009 ; 26 : 126-132.
23 Lee SJ, et al : Treatment of upper eyelid retraction related to thyroid-associated ophthalmology using subconjunctival triamcinolone injections. Graefes Arch Clin Exp Ophthalmol 2013 ; 251 : 261-270.
24 Mouritis MP, et al : Radiotherapy for Graves' orbitopathy : randomised placebo-controlled study. Lancet 2000 ; 355 : 1505-1509.